Recent

% | $
Quotes you view appear here for quick access.

DexCom, Inc. (DXCM) Message Board

  • jtlongbellsouth jtlongbellsouth Jan 5, 2014 5:00 PM Flag

    Oh No --- Needle-free glucose monitoring in the works

    The need to continually self-monitor glucose levels is an all too familiar task for people living with diabetes. Unfortunately, frequent needle pricks, drawing blood and covering expenses all come with the territory.

    For diabetics on higher insulin doses, this could mean getting stuck with needles many times a day.

    Echo Therapeutics is poised to change this protocol by taking the needle out of the equation. Echo recently announced plans to begin marketing its product to diabetics in Europe and will complete its final U.S. to test in 2014 on its flagship product – a needle-free glucose monitoring device called the Symphony CGM System.

    Unlike other devices on the market, this wireless transdermal system doesn’t require the glucose sensor to be inserted into the skin. This means no needles, no blood, and no pain. Skin permeation technology is Echo’s area of specialty). Pending FDA approval, the company plans to commercialize the Symphony CGM System for use in hospital critical care units in the U.S. and expand into diabetes patients and pediatrics later in the year.

    “For me, I would jump at the opportunity to no longer use needles,” said Louise Kuchynskas, 58, who’s been battling diabetes since childhood. Her diagnosis requires four daily insulin injections, in addition to six glucose tests a day.

    “I have to take the machines with me wherever I go,” said Kuchynskas. “It’s not easy, and it leaves my fingers tender. Sometimes I feel like all I do is poke myself with needles.”

    According to the National Diabetes Education Program, 25.8 million Americans have diabetes.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Compare with this :
      ---
      Health News Powered by Metro.us
      Needle-free glucose monitoring in the works

      The need to continually self-monitor glucose levels is an all too familiar task for people living with diabetes. Unfortunately, frequent needle pricks, drawing blood and covering expenses all come with the territory.

      For diabetics on higher insulin doses, this could mean getting stuck with needles several times a day.

      Echo Therapeutics seeks to change this protocol by taking the needle out of the equation. Echo recently announced plans to initiate regulatory trials in Europe and the U.S. to test its pet project – a needle-free glucose monitoring device called the Symphony tCGM System.

      Unlike other devices on the market, this wireless transdermal system doesn’t require the glucose censor to be inserted into the skin. This means no needles, no blood (skin permeation technology is Echo’s area of specialty). Pending FDA approval, the company plans to commercialize the Symphony tCGM System for use in hospital critical care units. The device is also being developed for outpatient use for people with diabetes.

      “For me, I would jump at the opportunity to no longer use needles,” said Louise Kuchynskas, 58, who’s been battling diabetes since childhood. Her diagnosis requires four daily insulin injections, in addition to six glucose tests a day.

      “I have to take the machine with me wherever I go,” said Kuchynskas. “It’s not easy, and it leaves my fingers tender. Sometimes I feel like all I do is poke myself with needles.”

      According to the National Diabetes Education Program, 25.8 million Americans have diabetes.

      Source: Echo Therapeutics
      ---
      Isn't it amazing ? Internet is wonderful thing - this page is dated December 19th. What date is on yours ?
      I'd like to know when "pet project" became "flagship" and some incorrect English phrase about 2014 appeared.

 
DXCM
83.41+1.71(+2.09%)Jul 28 4:00 PMEDT